Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for autosomal dominant polycystic kidney disease
IRCT2012102111194N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Tehran University of Medical Sciences. Started Feb 2013; status: completed.
02
Drugs
metformin
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on IRCT2012102111194N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012102111194N1.